Esperion Therapeutics
ESPR
ESPR
188 hedge funds and large institutions have $277M invested in Esperion Therapeutics in 2024 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 55 increasing their positions, 44 reducing their positions, and 25 closing their positions.
Holders
188
Holders Change
+6
Holders Change %
+3.3%
% of All Funds
2.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
33
Increased
55
Reduced
44
Closed
25
Calls
$5.22M
Puts
$4.13M
Net Calls
+$1.09M
Net Calls Change
+$204K
Top Buyers
1 |
1
Morgan Stanley
New York
|
$13.9M |
2 |
ICM
2
Indaba Capital Management
San Francisco,
California
|
$6.6M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$3.86M |
4 |
4
Goldman Sachs
New York
|
$6.06M |
5 |
WA
5
Wasatch Advisors
Salt Lake City,
Utah
|
$53.9M |